These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17387603)

  • 1. Dosage form development, in vitro release kinetics, and in vitro-in vivo correlation for leuprolide released from an implantable multi-reservoir array.
    Prescott JH; Krieger TJ; Lipka S; Staples MA
    Pharm Res; 2007 Jul; 24(7):1252-61. PubMed ID: 17387603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase-sensitive polymer-based controlled delivery systems of leuprolide acetate: in vitro release, biocompatibility, and in vivo absorption in rabbits.
    Singh S; Singh J
    Int J Pharm; 2007 Jan; 328(1):42-8. PubMed ID: 16959451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An in vivo/in vitro comparison with a leuprolide osmotic implant for the treatment of prostate cancer.
    Wright JC; Tao Leonard S; Stevenson CL; Beck JC; Chen G; Jao RM; Johnson PA; Leonard J; Skowronski RJ
    J Control Release; 2001 Jul; 75(1-2):1-10. PubMed ID: 11451492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The in vivo transformation and pharmacokinetic properties of a liquid crystalline drug delivery system.
    Otte A; Báez-Santos YM; Mun EA; Soh BK; Lee YN; Park K
    Int J Pharm; 2017 Oct; 532(1):345-351. PubMed ID: 28844902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro release and clinical pharmacokinetics of leuprolide from Luphere 3M Depot, a 3-month release formulation of leuprolide acetate.
    Park S; Kim DH; Kim Y; Park JH; Lee M; Song IS; Shim CK
    Drug Dev Ind Pharm; 2017 Mar; 43(3):441-447. PubMed ID: 27824264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo evaluation of an oral self-microemulsifying drug delivery system (SMEDDS) for leuprorelin.
    Hintzen F; Perera G; Hauptstein S; Müller C; Laffleur F; Bernkop-Schnürch A
    Int J Pharm; 2014 Sep; 472(1-2):20-6. PubMed ID: 24879935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A semi-mechanistic integrated pharmacokinetic/pharmacodynamic model of the testosterone effects of the gonadotropin-releasing hormone agonist leuprolide in prostate cancer patients.
    Lim CN; Salem AH
    Clin Pharmacokinet; 2015 Sep; 54(9):963-73. PubMed ID: 25791895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained activity and release of leuprolide acetate from an in situ forming polymeric implant.
    Ravivarapu HB; Moyer KL; Dunn RL
    AAPS PharmSciTech; 2000 Feb; 1(1):E1. PubMed ID: 14727850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ forming microparticle system for controlled delivery of leuprolide acetate: influence of the formulation and processing parameters.
    Luan X; Bodmeier R
    Eur J Pharm Sci; 2006 Feb; 27(2-3):143-9. PubMed ID: 16243496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term stability and in vitro release of hPTH(1-34) from a multi-reservoir array.
    Proos ER; Prescott JH; Staples MA
    Pharm Res; 2008 Jun; 25(6):1387-95. PubMed ID: 18266089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial Leuprolide Acetate Release from Poly(d,l-lactide-
    Li Z; Mu H; Larsen SW; Jensen H; Østergaard J
    Mol Pharm; 2020 Dec; 17(12):4522-4532. PubMed ID: 33164519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a cage implant system for assessing in vivo performance of long-acting release microspheres.
    Doty AC; Hirota K; Olsen KF; Sakamoto N; Ackermann R; Feng MR; Wang Y; Choi S; Qu W; Schwendeman A; Schwendeman SP
    Biomaterials; 2016 Dec; 109():88-96. PubMed ID: 27693924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel approach for the intravenous delivery of leuprolide using core-cross-linked polymeric micelles.
    Hu Q; van Gaal EV; Brundel P; Ippel H; Hackeng T; Rijcken CJ; Storm G; Hennink WE; Prakash J
    J Control Release; 2015 May; 205():98-108. PubMed ID: 25583642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modifying the release of leuprolide from spray dried OED microparticles.
    Alcock R; Blair JA; O'Mahony DJ; Raoof A; Quirk AV
    J Control Release; 2002 Aug; 82(2-3):429-40. PubMed ID: 12175755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new injectable liquid crystal system for one month delivery of leuprolide.
    Ki MH; Lim JL; Ko JY; Park SH; Kim JE; Cho HJ; Park ES; Kim DD
    J Control Release; 2014 Jul; 185():62-70. PubMed ID: 24794897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Manufacturing Variables and Raw Materials on the Composition-Equivalent PLGA Microspheres for 1-Month Controlled Release of Leuprolide.
    Zhou J; Walker J; Ackermann R; Olsen K; Hong JKY; Wang Y; Schwendeman SP
    Mol Pharm; 2020 May; 17(5):1502-1515. PubMed ID: 32074448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MEMS fabricated chip for an implantable drug delivery device.
    Sbiaa Z
    Conf Proc IEEE Eng Med Biol Soc; 2006; 2006():5621-4. PubMed ID: 17947154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the pharmacokinetics and pharmacodynamics of two leuprolide acetate 45 mg 6-month depot formulations in patients with prostate cancer.
    Mostafa NM; Chwalisz K; Larsen L; Mattia-Goldberg C; Spitz A; Pradhan RS
    Clin Pharmacol Drug Dev; 2014 Jul; 3(4):270-5. PubMed ID: 27128832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation development and human in vitro-in vivo correlation for a novel, monolithic controlled-release matrix system of high load and highly water-soluble drug niacin.
    Turner S; Federici C; Hite M; Fassihi R
    Drug Dev Ind Pharm; 2004 Sep; 30(8):797-807. PubMed ID: 15521326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nature of peptide interactions with acid end-group PLGAs and facile aqueous-based microencapsulation of therapeutic peptides.
    Sophocleous AM; Desai KG; Mazzara JM; Tong L; Cheng JX; Olsen KF; Schwendeman SP
    J Control Release; 2013 Dec; 172(3):662-70. PubMed ID: 24021356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.